Publications

  1. Kim, R.G.; McDonell, C.; McKinney, J.; Catalli, L.; Price, J.C.; Morris, M.D. Staff-Facilitated Telemedicine Care Delivery for Treatment of Hepatitis C Infection Among People Who Inject Drugs. Healthcare 2023, 11, x.
  2. Campusano C*, Kanner R, Mconell C*, Morris MD, Duarte M, Price JC. High prevalence of hepatitis B virus susceptibility among persons undergoing community-based hepatitis C virus treatment. Harm Red Journal. 2023 Dec 20.
  3. Hill Weller L*, Rubinsky AD, Shade SB, Liu F, Cheng I, Lopez G, Robertson A, Smith J, Dang K, Leiva C, Rubin S, Martinez SM, BibbinsDomingo K, Morris MD. Lessons learned from implementing a diversity, equity, and inclusion curriculum for health research professionals at a large academic research institution. J Clin Trans Sci, 2023 Dec 13.
  4. Rennels C*, Murthy SG, Handley MA, Morris MD, Alldredge BK, Dahiya P, Jagsi R, Kerns JL, Mangurian C. Informal Caregiving Among Faculty at a Large Academic Health Sciences University in the United States: an Opportunity for Policy Changes. Acad Psychiatry. 2023 Oct 11. PMID: 37821717
  5. Morris MD, McDonell C, Luetkemeyer AF, Thawley R, McKinney J, Price JC. Community-Based Point-of-Diagnosis Hepatitis C Treatment for Marginalized Populations: A Nonrandomized Controlled Trial. JAMA Netw Open. 2023 10 02; 6(10):e2338792. PMID: 37862013. PMCID: PMC10589813
  6. Cribb Fabersunne C*, Lee SY, McBride D, Zahir A*, Gallegos-Castillo A, LeWinn KZ, Morris MD. Exclusionary School Discipline and School Achievement for Middle and High School Students, by Race and Ethnicity. JAMA Netw Open. 2023 10 02; 6(10):e2338989. PMID: 37862011. PMCID: PMC10589805
  7. Morris MD, McDonell C*, Kim RG, Laguardia Y, Kanner R, Price JC. A pilot study to understand and respond to loss, theft, and misplacement of hepatitis C treatment medication for people who inject drugs. Clin Liver Dis. 2023
  8. Kim RG*, McDonell C*, Burbank S, Morris MD, Price JC, Telemedicine Acceptability and Experience in a Marginalized Population at Risk for HCV, Gastro Hep Advances (2023), doi: https://doi.org/10.1016/j.gastha.2023.09.010. 
  9. Morris MD, McDonell C*, Kim RG*, Laguardia Y, Kanner R, Price JC. A pilot study to understand and respond to loss, theft, and misplacement of hepatitis C treatment medication for people who inject drugs. Clin Liver Dis (Hoboken). 2023 Sep; 22(3):81-84. PMID: 37799636. PMCID: PMC10550011
  10. McDonell C*, Li R, Runnels A*, Morris MD. Low-income San Franciscans' Access to Basic Needs during COVID Shelter-in-Place: A Focus on People Who Use Drugs. J Health Care Poor Underserved. 2023; 34(3):931-948. PMID: 38015130
  11. Artenie A*, Stone J, Facente SN, Fraser H*, Hecht J, Rhodes P, McFarland W, Wilson E, Hickman M, Vickerman P, Morris MD. Impact of HCV Testing and Treatment on HCV Transmission Among Men Who Have Sex With Men and Who Inject Drugs in San Francisco: A Modelling Analysis. J Infect Dis. 2023 09 15; 228(6):662-673. PMID: 37486337. PMCID: PMC10503949
  12. Artenie A*, Facente SN*, Patel S, Stone J, Hecht J, Rhodes P, McFarland W, Wilson E, Vickerman P, Morris MD. A cross-sectional study comparing men who have sex with men and inject drugs and people who inject drugs who are men and have sex with men in San Francisco: Implications for HIV and hepatitis C virus prevention. Health Sci Rep. 2022 Jul; 5(4):e704. PMID: 35844825. PMCID: PMC9277112
  13. Facente SN*, Grinstein R, Bruhn R, Kaidarova Z, Wilson E, Hecht J, Burk K, Grebe E, Morris MD. Hepatitis C prevalence and key population size estimate updates in San Francisco: 2015 to 2019. PLoS One. 2022; 17(5):e0267902. PMID: 35544483. PMCID: PMC9094540
  14. Sarah Raifman, Michelle A. DeVost, Jean C. Digitale, Yea-Hung Chen, Meghan D. Morris. Respondent-Driven Sampling: a Sampling Method for Hard-to-Reach Populations and Beyond. Current Epidemiology Reports. 2022 Mar 1; 9(1):38-47.
  15. Mirzazadeh A, Hosseini-Hooshyar S, Shahesmaeili A, Sharafi H, Shafiei M, Zarei J, Mousavian G, Tavakoli F, Ghalekhani N, Shokoohi M, Khezri M, Mehmandoost S, Shojaei MR, Karamouzian M, Briceno A, Morris MD, Alavian SM, Haghdoost AA, Sharifi H, Page KA. An on-site community-based model for hepatitis C screening, diagnosis, and treatment among people who inject drugs in Kerman, Iran: The Rostam study. Int J Drug Policy. 2022 Jan 21; 102:103580. PMID: 35074607
  16. Mirzazadeh A, Chen YH, Lin J, Burk K, Wilson EC, Miller D, Veloso D, McFarland W, Morris MD. Progress toward closing gaps in the hepatitis C virus cascade of care for people who inject drugs in San Francisco. PLoS One. 2021; 16(4):e0249585. PMID: 33798243. PMCID: PMC8018615
  17. Facente SN*, Patel S, Hecht J, Wilson E, McFarland W, Page K, Vickerman P, Fraser H, Burk K, Morris MD. Hepatitis C care cascades for three populations at high risk: low-income trans women, young people who inject drugs, and men who have sex with men and inject drugs. Clin Infect Dis. 2021 Mar 26. PMID: 33768236
  18. Arum C, Fraser H, Artenie AA, Bivegete S, Trickey A, Alary M, Astemborski J, Iversen J, Lim AG, MacGregor L, Morris M, Ong JJ, Platt L, Sack-Davis R, van Santen DK, Solomon SS, Sypsa V, Valencia J, Van Den Boom W, Walker JG, Ward Z, Stone J, Vickerman P, Homelessness, HIV, and HCV Review Collaborative Group . Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. Lancet Public Health. 2021 Mar 26. PMID: 33780656. PMCID: PMC8097637
  19. Dang KV*, Rerolle F*, Ackley SF, Irish AM, Mehta KM, Bailey I, Fair E, Miller C, Bibbins-Domingo K, Wong-Moy E, Glymour MM, Morris MD. A Randomized Study to Assess the Effect of Including the Graduate Record Examinations (GRE) Results on Reviewers Scores for Underrepresented Minorities. Am J Epidemiol. 2021 Mar 18. PMID: 33738464
  20. Tully DC, Hahn JA, Bean DJ, Evans JL, Morris MD, Page K, Allen TM. Identification of Genetically Related HCV Infections Among Self Described Injecting Partnerships. Clin Infect Dis. 2021 Aug 27. PMID: 34448809
  21. Mirzazadeh A, Facente SN, Burk K, Kahn JG, Morris MD, End Hep C SFc. Hepatitis C Mortality Trends in San Francisco: Can We Reach Elimination Targets? Ann Epidemiol. 2021 Oct 23. PMID: 34700016
  22. Stockman JK, Syvertsen JL, Hayashi HD, Ludwig-Barron N, Tsuyuki K, Morris MD, Palinkas LA. "Violence and love and drugs…it all goes hand in hand": A mixed methods analysis of the substance abuse, violence, and HIV/AIDS syndemic among women who use methamphetamine. Subst Abus. 2021;42(4):821-831. PMID: 33492198.
  23. DeVilbiss EA, Weuve J, Fink DS, Morris MD, Arah OA, Radoc JG, Datta GD, Abuelezam NN, Lopez DS, Johnson DA, Branas CC, Schisterman EF. Assessing Representation and Perceived Inclusion among Members in the Society for Epidemiologic Research. Am J Epidemiol. 2020 Jan 07. PMID: 31907518
  24. Gilman SE, Arah OA, Bates LM, Branas CC, Cozier YC, Datta GD, DeVilbiss EA, Fink DS, Hajat A, Johnson DA, Lopez DS, Morris MD, Weuve J, Abuelezam NN. The Society for Epidemiologic Research and the Future of Diversity and Inclusion in Epidemiology. Am J Epidemiol. 2020 10 01; 189(10):1049-1052. PMID: 32602528. PMCID: PMC7666411
  25. Geddes L, Iversen J, Wand H, Esmaeili A, Tsui J, Hellard M, Dore G, Grebely J, Dietze P, Bruneau J, Prins M, Morris MD, Shoukry NH, Lloyd AR, Kim AY, Lauer G, Cox AL, Page K, Maher L. Sex Discrepancies in the Protective Effect of Opioid Agonist Therapy on Incident Hepatitis C Infection. Clin Infect Dis. 2020 Jan 01; 70(1):123-131. PMID: 30816419. PMCID: PMC6912156
  26. Morris MD, Yen IH, Shiboski S, Evans JL, Page K. Housing Stability and Hepatitis C Infection for Young Adults Who Inject Drugs: Examining the Relationship of Consistent and Intermittent Housing Status on HCV Infection Risk. J Urban Health. 2020 Sep 08. PMID: 32901411
  27. Page K, Evans J, Morris M, Vickerman P, Hahn J. Injection partner mixing: higher risk of HCV among young adults who inject drugs with younger injecting partners. J Drug Policy. Accepted Aug 2019.
  28. Mirzazadeh A, Le Marchand C, Morris MD, Milloy M, Hahn J, Maher L, Grebely J, Kim AY, Lauer G, Cox AL, Hellard M, Dietze P, Bruneau J, Shoukry NH, Dore GJ, Lloyd AR, Prins M, Page K; InC3 Collaborative. Risk of hepatitis C virus infection in men who inject drugs with or without male-to-male sex exposure. Hepatology. Under Review
  29. Rodrigo C, Leung P, Lloyd AR, Bull RA, Luciani F, Grebely J, Dore GJ, Applegate T, Morris MD, Page K, Bruneau J, Cox AL, Osburn W, Kim AY, Shoukry NH, Lauer GM, Maher L, Schinkel J, Prins M, Hellard M, Eltahla AA; InC3 Collaborative. Genomic variability of within-host hepatitis C variants in acute infection. J Viral Hepat. 2019 Apr;26(4):476- 484.
  30. Morris MD, Andrew E, Tan JY, Maher L, Hoff C, Darbes L, Page K. Injecting-related trust, cooperation, intimacy, and power as key factors influencing risk perception among drug injecting partnerships. PLoS One. 2019; 14(5):e0217811. PMID: 31150518. PMCID: PMC6544289
  31. Geddes L, Iversen J, Wand H, Esmaeili A, Tsui J, Hellard M, Dore G, Grebely J, Dietze P, Bruneau J, Prins M, Morris MD, Shoukry NH, Lloyd AR, Kim AY, Lauer G, Cox AL, Page K, Maher L; InC3 Collaborative. Sex discrepancies in the protective effect of opioid agonist therapy on incident hepatitis C infection. Clin Infect Dis. 2019 Feb 28.
  32. Hahn JA, Tully DC, Evans JL, Morris MD, Briceno A, Bean DJ, Allen TM, Page K. Role of HCV Viremia in Corroborated HCV Transmission Events Within Young Adult Injecting Partnerships. Open Forum Infect Dis. 2019 Apr; 6(4):ofz125. PMID: 31041340. PMCID: PMC6483127
  33. Mooney AC*, Neilands TB, Giannella E, Morris MD, Tulsky J, Glymour MM. Effects of a voter initiative on disparities in punishment severity for drug offenses across California counties. Soc Sci Med. 2019 Jun; 230:9- 19. PMID: 30947103
  34. Page K, Evans JL, Hahn JA, Vickerman P, Shiboski S, Morris MD. HCV incidence is associated with injecting partner age and HCV serostatus mixing in young adults who inject drugs in San Francisco. PLoS One. 2019; 14(12):e0226166. PMID: 31821365. PMCID: PMC6903751
  35. Morris MD, Mirzazadeh A, Evans JL, Briceno A, Coffin P, Hahn JA, Page KA. Treatment cascade for hepatitis C virus in young adult people who inject drugs in San Francisco: Low number treated. Drug Alcohol Depend. 2019 May 01; 198:133-135. PMID: 30921649. PMCID: PMC6482851
  36. Esmaeili A, Shokoohi M, Danesh A, Sharifi H, Karamouzian M, Haghdoost A, Shahesmaeili A, Akbarpour S, Morris MD, Mirzazadeh A. Dual Unsafe Injection and Sexual Behaviors for HIV Infection Among People Who Inject Drugs in Iran. AIDS Behav. 2018 Nov 20. PMID: 30460664. PMCID: PMC6527484
  37. Mooney AC*, Giannella E, Glymour MM, Neilands TB, Morris MD, Tulsky J, Sudhinaraset M. Racial/Ethnic Disparities in Arrests for Drug Possession After California Proposition 47, 2011-2016. Am J Public Health. 2018 Aug; 108(8):987-993. PMID: 29927653. PMCID: PMC6050868
  38. Facente SN*, Grebe E, Burk K, Morris MD, Murphy EL, Mirzazadeh A, Smith AA, Sanchez MA, Evans JL, Nishimura A, Raymond HF. Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for elimination. PLoS One. 2018; 13(4):e0195575. PMID: 29641546. PMCID: PMC5895024
  39. Ndayongeje J, Msami A, Laurent YI, Mwankemwa S, Makumbuli M, Ngonyani AM, Tiberio J, Welty S, Said C, Morris MD, McFarland W. Illicit Drug Users in the Tanzanian Hinterland: Population Size Estimation Through Key Informant-Driven Hot Spot Mapping. AIDS Behav. 2018 Jul; 22(Suppl 1):4-9. PMID: 29435795. PMCID: PMC6045962
  40. Facente SN, Grebe E, Burk K, Morris MD, Murphy EL, Mirzazadeh A, Smith AA, Sanchez MA, Evans JL, Nishimura A, Raymond HF, End Hep C SF. Correction: Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for elimination. PLoS One. 2018; 13(7):e0200866. PMID: 30001389. PMCID: PMC6042782
  41. Tiberio J*, Laurent YI, Ndayongeje J, Msami A, Welty S, Ngonyani A, Mwankemwa S, Makumbuli M, McFarland W, Morris MD. Context and characteristics of illicit drug use in coastal and interior Tanzania. Int J Drug Policy. Jan 2018. PMID: 29156310.
  42. Morris MD, Montgomery ME*, Briceno A, Evans JL, Andrew EVW, Page K, Hahn JA. A study of sexual relationship power among young women who inject drugs and their sexual partners. Subs Use Misuse. Dec 29 2017. PMID: 29286888.
  43. Morris MD, Brown B, Allen SA. Universal opt-out screening for hepatitis C virus (HCV) within correctional facilities is an effective intervention to improve public health. Int J Prison Health. 2017 Sep 11;13(3-4):192-199. PMID: 28914118.
  44. Esmaeili A, Mirzazadeh A, Morris MD, Hajarizadeh B, Sacks HS, Maher L, Grebely J, Kim AY, Lauer G, Cox AL, Hellard M, Dietze P, Bruneau J, Shoukry NH, Dore GJ, Lloyd AR, Prins M, Page K; InC3 Collaborative. The effect of female sex on hepatitis C incidence among people who inject drugs: results from the international multi-cohort InC3 Collaborative. Clin Infect Dis. 2017 Aug 24. PMID: 29020200.
  45. Morris MD, Neilands TB, Andrew E, Maher L, Page KA, Hahn JA. Development and validation of a novel scale for measuring interpersonal factors underlying injection drug using behaviors among injecting partnerships. Int J Drug Policy. 2017 Aug 9;48:54-62. PMID: 28804051.
  46. Morris MD, Shiboski S, Bruneau J, Hahn JA, Hellard M, Prins M, Cox AL, Dore G, Grebely J, Kim AY, Lauer GM, Lloyd A, Rice T, Shoukry N, Maher L, Page K; International Collaboration of Incident HIV and HCV in Injecting Cohorts (InC3).. Geographic Differences in Temporal Incidence Trends of Hepatitis C Virus Infection Among People Who Inject Drugs: The InC3 Collaboration. Clin Infect Dis. 2017 Apr 1;64(7):860-869. PMID: 28362947
  47. Eltahla AA, Rodrigo C, Betz-Stablein B, Grebely J, Applegate T, Luciani F, Schinkel J, Dore GJ, Page K, Bruneau J, Morris MD, Cox AL, Kim AY, Shoukry NH, Lauer GM, Maher L, Hellard M, Prins M, Lloyd AR, Bull RA; InC3 Study Group.. Analysis of resistance-associated substitutions in acute hepatitis C virus infection by deep sequencing across six genotypes and three continents. J Viral Hepat. 2017 Jan;24(1):37-42. Epub 2016 Sep 25. PMID: 27666440.
  48. Rodrigo C, Walker MR, Leung P, Eltahla AA, Grebely J, Dore GJ, Applegate T, Page K, Dwivedi S, Bruneau J, Morris MD, Cox AL, Osburn W, Kim AY, Schinkel J, Shoukry NH, Lauer GM, Maher L, Hellard M, Prins M, Luciani F, Lloyd AR, Bull RA. Limited naturally occurring escape in broadly neutralizing antibody epitopes in hepatitis C glycoprotein E2 and constrained sequence usage in acute infection. Infect Genet Evol. 2017 Jan 05. PMID: 28065804. PMCID: PMC5330849
  49. Rodrigo C, Eltahla AA, Bull RA, Grebely J, Dore GJ, Applegate T, Page K, Bruneau J, Morris MD, Cox AL, Osburn W, Kim AY, Schinkel J, Shoukry NH, Lauer GM, Maher L, Hellard M, Prins M, Estes C, Razavi H, Lloyd AR, Luciani F. Historical trends in the hepatitis C virus epidemics in North America and Australia. J Infect Dis. 2016 Aug 28. PMID: 27571901. PMCID: PMC5079374
  50. Baer RJ, Rogers EE, Partridge JC, Anderson JG, Morris M, Kuppermann M, Franck LS, Rand L, Jelliffe-Pawlowski LL. Population based risks of mortality and preterm morbidity by gestational age and birth weight. J Perinatol. 2016 Jul 28. PMID: 27467566
  51. Page K, Mirzazadeh A, Rice TM, Grebely J, Kim AY, Cox AL, Morris MD, Hellard M, Bruneau J, Shoukry NH, Dore GJ, Maher L, Lloyd AR, Lauer G, Prins M, McGovern BH. Interferon Lambda 4 Genotype Is Associated With Jaundice and Elevated Aminotransferase Levels During Acute Hepatitis C Virus Infection: Findings From the InC3 Collaborative. Open Forum Infect Dis. 2016 Jan; 3(1):ofw024. PMID: 26973850. PMCID: PMC4785397
  52. Hajarizadeh B, Grady B, Page K, Kim AY, McGovern BH, Cox AL, Rice TM, Sacks-Davis R, Bruneau J, Morris M, Amin J, Schinkel J, Applegate T, Maher L, Hellard M, Lloyd AR, Prins M, Dore GJ, Grebely J. Patterns of Hepatitis C Virus RNA Levels during Acute Infection: The InC3 Study. PLoS One. 2015; 10(4):e0122232. PMID: 25837807. PMCID: PMC4383375
  53. Sacks-Davis R, Grebely J, Dore GJ, Osburn W, Cox AL, Rice TM, Spelman T, Bruneau J, Prins M, Kim AY, McGovern BH, Shoukry NH, Schinkel J, Allen TM, Morris MD, Hajarizadeh B, Maher L, Lloyd AR, Page K, Hellard M. Hepatitis C virus reinfection and spontaneous clearance of reinfection - the InC3 study. J Infect Dis. 2015 Apr 15. PMID: 25883387
  54. Doyle JS, Deterding K, Grebely J, Wedemeyer H, Sacks-Davis R, Spelman T, Matthews G, Rice TM, Morris MD, McGovern BH, Kim AY, Bruneau J, Lloyd AR, Page K, Manns MP, Hellard ME, Dore GJ. Response to treatment following recently acquired hepatitis C virus infection in a multicentre collaborative cohort. J Viral Hepat. 2015 Dec; 22(12):1020-32. PMID: 26098993. PMCID: PMC4618180
  55. Morris MD, Bates A, Andrew E, Hahn J, Page K, Maher L. More than just someone to inject drugs with: Injecting within primary injection partnerships. Drug Alcohol Depend. 2015 Nov 1; 156:275-81. PMID: 26460140. PMCID: PMC4633359
  56. Morris MD*, Spelman T*, Zang G, Rice T, Page K, Maher L, Lloyd A, Grebely J, Dore GJ, Kim AY, Shoukry NH, Hellard M, Bruneau J on behalf of the International Collaborative of Incident HIV and Hepatitis C in Injecting Cohorts (InC3 Study). A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugs. BMC Journal of Epidemiology & Community Health; 2015 Aug; 69(8):745-52. PMID: 25814695. PMCID: PMC4515217*Indicates both authors contributed equally
  57. Evans JL, Morris MD, Yu M, Page K, Hahn JA. Concordance of risk behavior reporting within HCV serodiscordant injecting partnerships of young injection drug users in San Francisco, CA. Drug Alcohol Depend. 2014 Jul 4. PMID: 25034898. PMCID: PMC4471952
  58. Tracy D, Hahn JA, Fuller Lewis C, Evans J, Briceño A, Morris MD, Lum PJ, Page K. Higher risk of incident hepatitis C virus among young women who inject drugs compared with young men in association with sexual relationships: a prospective analysis from the UFO Study cohort. BMJ Open. 2014; 4(5):e004988. PMID: 24875490. PMCID: PMC4039809
  59. Morris MD, Evans J, Montgomery M, Yu M, Briceno A, Page K, Hahn JA. Intimate Injection Partnerships Are at Elevated Risk of High-Risk Injecting: A Multi-Level Longitudinal Study of HCV-Serodiscordant Injection Partnerships in San Francisco, CA. PLoS One. 2014; 9(10):e109282. PMID: 25286346
  60. Hajarizadeh B, Grady B, Page K, Kim AY, McGovern BH, Cox AL, Rice TM, Sacks-Davis R, Bruneau J, Morris M, Amin J, Schinkel J, Applegate T, Maher L, Hellard M, Lloyd AR, Prins M, Geskus RB, Dore GJ, Grebely J. Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: The InC(3) Study. J Clin Virol. 2014 Nov; 61(3):430-4. PMID: 25256151. PMCID: PMC4279031
  61. Grebely J, Page K, Sacks-Davis R, van der Loeff MS, Rice TM, Bruneau J, Morris MD, Hajarizadeh B, Amin J, Cox AL, Kim AY, McGovern BH, Schinkel J, George J, Shoukry NH, Lauer GM, Maher L, Lloyd AR, Hellard M, Dore GJ, Prins M. The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology. 2014 Jan; 59(1):109-20. PMID: 23908124. PMCID: PMC3972017
  62. Page K, Morris MD, Hahn JA, Maher L, Prins M. Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention. Clin Infect Dis. 2013 Aug; 57 Suppl 2:S32-8. PMID: 23884063. PMCID: PMC3722077
  63. Morris MD, Quezada L, Bhat P, Moser K, Smith J, Perez H, LaniadoLaborin R, Estrada-Guzman J, Rodwell TC. Social, economic, and psychological impacts of MDR-TB treatment in Tijuana, Mexico: a patient's perspective. Int J Tuberc Lung Dis. 2013 Jul; 17(7):954-60. PMID: 23743315. PMCID: PMC3769163
  64. Grebely J, Morris MD, Rice TM, Bruneau J, Cox AL, Kim AY, McGovern BH, Shoukry NH, Lauer G, Maher L, Lloyd AR, Hellard M, Prins M, Dore GJ, Page K. Cohort Profile: The International Collaboration of Incident HIV and Hepatitis C in Injecting Cohorts (InC3) Study. Int J Epidemiol. 2013 Dec; 42(6):1649-59. PMID: 23203695. PMCID: PMC3887561
  65. Briceño A, Morris MD, Evans J, Raymond HF, Page K. Characteristics and health service utilization in two samples of young injection drug users recruited using direct and referral methods in San Francisco, California. J Alcohol Drug Depend. 2013 Aug; 1(5). PMID: 26236757. PMCID: PMC4519198
  66. Morris MD, Lemus H, Wagner KD, Martinez G, Lozada R, Gómez RM, Strathdee SA. Factors associated with pathways toward concurrent sex work and injection drug use among female sex workers who inject drugs in northern Mexico. Addiction. 2013 Jan; 108(1):161-70. PMID: 22775475. PMCID: PMC3481016
  67. Stockman JK, Morris MD, Martinez G, Lozada R, Patterson TL, Ulibarri MD, Vera A, Strathdee SA. Prevalence and correlates of female condom use and interest among injection drug-using female sex workers in two Mexico-US border cities. AIDS Behav. 2012 Oct; 16(7):1877-86. PMID: 22711225. PMCID: PMC3461315
  68. Grebely J, Prins M, Hellard M, Cox AL, Osburn WO, Lauer G, Page K, Lloyd AR, Morris M, Dore GJ; InC3 Study. Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine. Lancet Infect Dis. 2012 May; 12(5):408-14. PMID: 22541630. PMCID: PMC3608418
  69. Morris MD, Brouwer KC, Lozada RM, Gallardo M, Vera A, Strathdee SA. "Injection first": a unique group of injection drug users in Tijuana, Mexico. Am J Addict. 2012 Jan-Feb;21(1):23-30. PMID: 22211343.
  70. Morris MD, Case P, Robertson AM, Lozada R, Vera A, Clapp JD, Medina-Mora ME, Strathdee SA. Prevalence and correlates of 'agua celeste' use among female sex workers who inject drugs in Ciudad Juarez, Mexico. Drug Alcohol Depend. 2011 Sep 1; 117(2-3):219-25. PMID: 21441001. PMCID: PMC3148352
  71. Rondinelli AJ, Morris MD, Rodwell TC, Moser KS, Paida P, Popper ST, Brouwer KC. Under- and over-nutrition among refugees in San Diego County, California. J Immigr Minor Health. 2011 Feb; 13(1):161-8. PMID: 20505992
  72. Morris MD, Popper ST, Rodwell TC, Brodine SK, Brouwer KC. Healthcare barriers of refugees post-resettlement. J Community Health. 2009 Dec; 34(6):529-38. PMID: 19705264
  73. *Morris MD*, Liang B. Human Papilloma Virus Vaccine: addressing policy issues to fulfill social potential. J Biolaw & Business. 2006 December